Breaking Down China Building Material Test & Certification Group Co., Ltd. Financial Health: Key Insights for Investors

Dive into a data-driven look at China Building Material Test & Certification Group Co., Ltd. (603060.SS) where 2024 revenue stood at CNY 2.62 billion (down 1.63% year-over-year) with TTM revenue at CNY 2.68 billion, Q3 2025 revenue up to CNY 656.11 million (+7.42% YoY), and revenue per employee of CNY 488,760; assess profitability pressures after a 2024 net income of CNY 173.58 million (-20.79%), a net margin of 6.96%, EPS of CNY 0.22 (TTM 0.25), ROE 10.04%, operating margin 10.41% and EBITDA margin 16.06%; weigh capital structure with a debt-to-equity ratio of 0.82, total debt CNY 2.16 billion against equity CNY 2.65 billion, interest coverage 5.17 and debt/EBITDA 4.51; consider liquidity signals-cash CNY 631.74 million, working capital CNY 836.21 million, negative net cash of CNY -1.53 billion, operating cash flow CNY 267.04 million and free cash flow CNY 75.79 million-alongside valuation metrics including market cap CNY 4.86 billion, P/S 2.02, P/E 27.97, P/B 2.53, EV/EBITDA 15.79 and EV/FCF 99.94, with a dividend yield of 1.54% and Altman Z-Score 2.1; appraise risks such as a 15% employee turnover (2022), ~30% of revenue from overseas, rising bad debt provisions (+8% YoY, 2022), capex at 15% of revenue (2022) and a beta of 0.375, and explore growth avenues tied to its state-founded positioning, intelligent manufacturing services and regulatory foothold-read on for the full financial breakdown and investor implications.

China Building Material Test & Certification Group Co., Ltd. (603060.SS) - Revenue Analysis

• FY 2024 revenue: CNY 2.62 billion (-1.63% YoY)
• TTM revenue: CNY 2.68 billion (-1.35% YoY)
• Q3 2025 revenue: CNY 656.11 million (+7.42% YoY)
• Revenue per employee: ~CNY 488,760
• Market capitalization: CNY 4.86 billion; Shares outstanding: 803.96 million
• Price-to-sales (P/S) ratio: 2.02

China Building Material Test & Certification Group Co., Ltd. (603060.SS) Profitability Metrics

• Net income (2024): CNY 173.58 million (-20.79% YoY)
• Net profit margin: 6.96%
• Operating margin: 10.41%
• EBITDA margin: 16.06%
• Return on equity (ROE): 10.04%
• Earnings per share (EPS): CNY 0.22; TTM EPS: CNY 0.25

• Despite a drop in net income, the 10.41% operating margin and 16.06% EBITDA margin point to resilient core operations and cost management.
• The gap between EPS (CNY 0.22) and TTM EPS (CNY 0.25) suggests recent quarterly pressure on earnings relative to the prior trailing year.
• ROE at 10.04% remains within a range that can attract yield-focused investors, though the net income decline warrants attention to revenue and cost drivers.

China Building Material Test & Certification Group Co., Ltd. (603060.SS) - Debt vs. Equity Structure

• Debt-to-equity ratio: 0.82 - balanced leverage relative to shareholders' equity.
• Total debt: CNY 2.16 billion (total interest-bearing liabilities).
• Equity (book value): CNY 2.65 billion (shareholders' equity on the balance sheet).
• Interest coverage ratio: 5.17 - EBIT covers interest expense by just over five times.
• Debt-to-EBITDA: 4.51 - moderate leverage when measured against operating cash-generation proxies.
• Current ratio: 1.49 - adequate short-term liquidity to cover current liabilities.
• Quick ratio: 1.30 - sufficient immediate-liquid assets to meet near-term obligations.

• Implied metrics: using Debt-to-EBITDA of 4.51 implies EBITDA ≈ CNY 479.2 million (2.16bn / 4.51).
• Leverage context: debt-to-equity of 0.82 signals the company leverages debt significantly but remains under 1.0, indicating equity still exceeds debt on the balance sheet.
• Liquidity context: current and quick ratios above 1.0 indicate sufficient short-term cover, with a comfortable buffer for working-capital needs.

China Building Material Test & Certification Group Co., Ltd. (603060.SS) Liquidity and Solvency

• Cash and cash equivalents: CNY 631.74 million - a short-term liquidity cushion.
• Working capital: CNY 836.21 million - indicates the company can cover near-term obligations.
• Net cash position: CNY -1.53 billion - reflects higher total debt over cash.
• Operating cash flow: CNY 267.04 million - solid cash generated from core operations.
• Capital expenditures (CapEx): CNY 191.24 million - ongoing investment in operations and capacity.
• Free cash flow: CNY 75.79 million - cash remaining after CapEx for discretionary use.

China Building Material Test & Certification Group Co., Ltd. (603060.SS) - Valuation Analysis

• Price-to-Earnings (P/E): 27.97 - trading at a premium versus industry peers.
• Price-to-Book (P/B): 2.53 - market values the company above its book equity.
• EV/EBITDA: 15.79 - valuation relative to operating earnings.
• EV/FCF: 99.94 - very high relative to free cash flow, signaling limited cash-based valuation support.
• Dividend Yield: 1.54% - modest income return for shareholders.
• Altman Z-Score: 2.1 - indicates moderate bankruptcy risk (zone of concern between safe and distressed).

• Valuation implications for investors:
• Premium P/E and P/B suggest market expectations of above-average earnings growth or higher quality assets/pricing power.
• High EV/FCF warns that current market valuation may be built on expected improvements in cash generation; downside risk if cash flow underperforms.
• Altman Z-Score near 2.1 recommends monitoring liquidity, leverage, and working capital trends.
• Dividend yield provides limited cushion versus valuation multiple risk.

China Building Material Test & Certification Group Co., Ltd. (603060.SS) - Risk Factors

• Operational risk: workforce dynamics - the company reported a 15% employee turnover rate in 2022, increasing recruitment and training costs and creating potential service-capacity gaps in specialized testing and certification functions.
• Financial exposure: currency and credit - roughly 30% of revenue is derived from overseas markets, heightening vulnerability to foreign-exchange volatility; concurrently, bad debt provisions rose 8% year-over-year in 2022, signaling increased counterparty credit risk.
• Industry demand risk: construction slowdown - the domestic construction industry's growth decelerated to 3.5% in 2023, directly reducing demand for third-party testing and certification services and pressuring utilization and pricing.
• Capital intensity and liquidity: capex strain - capital expenditures climbed to 15% of revenue in 2022, reflecting heavy investment in equipment, labs and digital platforms that may compress short-term free cash flow and liquidity metrics.
• Market volatility profile: low beta - a reported beta of 0.375 indicates substantially lower correlation and volatility relative to the broader market, which can be attractive for risk-averse investors but may also limit upside in strong bull markets.

• Credit and liquidity indicators to monitor: receivables aging, days sales outstanding (DSO), allowance for doubtful accounts, operating cash flow and current ratio (post-capex).
• Operational indicators to monitor: employee retention metrics, time-to-fill technical roles, training spend as % of payroll, and lab utilization rates.
• Market/FX indicators to monitor: revenue split by currency, hedging coverage, and margin sensitivity to 1% currency movement.

China Building Material Test & Certification Group Co., Ltd. (603060.SS) - Growth Opportunities

• Strategic position: state-founded heritage and regulatory integration enable preferential access to infrastructure and compliance-driven demand.
• Service breadth: core materials testing augmented by intelligent manufacturing support and instrument verification positions the company as an integrated technical partner across construction and industrial value chains.
• Market sensitivity: revenue streams are correlated with domestic construction/manufacturing cycles and policy directives, providing stability during regulatory-led spending but exposure to cyclical slowdowns.

• Technology-led expansion: deliberate shift into intelligent manufacturing and higher-value technical services can expand addressable market and raise ASPs (average service prices).
• Capital intensity: investments in new technologies and lab/equipment upgrades raise capital expenditure requirements and can compress free cash flow in the near term.
• Risk profile: a measured beta (0.375) reflects lower market volatility relative to the broader market and may suit risk-averse investors seeking defensive, policy-aligned exposure.

• Cash-flow dynamics: 15% capex-to-revenue in 2022 indicates meaningful reinvestment - beneficial for capability building but a constraint on distributable cash until returns materialize.
• Margin improvement paths: higher-value technical and intelligent manufacturing services can uplift gross margins versus commoditized testing work if commercialized effectively.
• Capital allocation trade-offs: balancing continued CapEx and R&D with working capital and potential dividend expectations will be a central governance decision for sustainable growth.